DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy
Dynamin 2 (DNM2) is a ubiquitously expressed GTPase regulating membrane trafficking and cytoskeleton dynamics. Heterozygous dominant mutations in DNM2 cause centronuclear myopathy (CNM), associated with muscle weakness and atrophy and histopathological hallmarks as fiber hypotrophy and organelles mi...
Saved in:
Main Authors: | Juliana de Carvalho Neves (Author), Foteini Moschovaki-Filippidou (Author), Johann Böhm (Author), Jocelyn Laporte (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A dog model for centronuclear myopathy carrying the most common DNM2 mutation
by: Johann Böhm, et al.
Published: (2022) -
A rare case of centronuclear myopathy with DNM2 mutation: genotype-phenotype correlation
by: Amir Ghorbani Aghbolaghi, et al.
Published: (2017) -
Allele-Specific CRISPR/Cas9 Correction of a Heterozygous DNM2 Mutation Rescues Centronuclear Myopathy Cell Phenotypes
by: Aymen Rabai, et al.
Published: (2019) -
Phospholamban overexpression in mice causes a centronuclear myopathy-like phenotype
by: Val A. Fajardo, et al.
Published: (2015) -
Characterization of a novel zebrafish model of SPEG-related centronuclear myopathy
by: Karla G. Espinosa, et al.
Published: (2022)